• 1
    Robertson JL. Spontaneous renal disease in dogs. J Toxicol Pathol 1986;14:101108.
  • 2
    Pomeroy MJ, Robertson JL. The relationship of age, sex, and glomerular location to the development of spontaneous lesions in the canine kidney: Analysis of a life-span study. J Toxicol Pathol 2004;32:237242.
  • 3
    Chertow GM, Hsu CY, Johansen KL. The enlarging body of evidence: Obesity and chronic kidney disease. J Am Soc Nephrol 2006;17:15011502.
  • 4
    Kopple JD, Feroze U. The effect of obesity on chronic kidney disease. J Renal Nutr 2011;21:6671.
  • 5
    German AJ. The growing problem of obesity in dogs and cats. J Nutr 2006;136:1940S1946S.
  • 6
    Murgier P, Jakins A, Bexfield N, Archer J. Comparison of semiquantitative test strips, urine protein electrophoresis, and an immunoturbidimetric assay for measuring microalbuminuria in dogs. Vet Clin Pathol 2009;38:485492.
  • 7
    Smets PM, Meyer E, Maddens BE, et al. Urinary markers in healthy young and aged dogs and dogs with chronic kidney disease. J Vet Intern Med 2010;24:6572.
  • 8
    Watson ADJ. Urine specific gravity. Aust Vet J 1998;76:392398.
  • 9
    Maddens BE, Daminet S, Demeyere K, et al. Validation of immunoassays for the candidate renal markers C-reactive protein, immunoglobulin G, thromboxane B2 and retinol binding protein in canine urine. Vet Immunol Immunopathol 2010;134:259264.
  • 10
    Wehner A, Hartmann K, Hirschberger J. Utility of serum cystatin C as a clinical measure of renal function in dogs. J Am Anim Hosp Assoc 2008;44:131138.
  • 11
    Ferechide D, Radulescu D. Hyperhomocysteinemia in renal diseases. J Med Life 2009;2:5359.
  • 12
    Friedman AN, Bostom AG, Selhub J, et al. The kidney and homocysteine metabolism. J Am Soc Nephrol 2001;12:21812189.
  • 13
    Stam F, van Guldener C, Schalkwijk CG, et al. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant 2003;18:892898.
  • 14
    Rossi S, Rossi G, Giordano A, Paltrinieri S. Homocysteine measurement by an enzymatic method and potential role of homocysteine as a biomarker in dogs. J Vet Diagn Invest 2008;20:644649.
  • 15
    Laterza OF, Price CP, ScottMG. CystatinC: an improved estimator of glomerular filtration rate? Clin Chem 2002;48:699707.
  • 16
    Séronie-Vivien S, Delanaye P, Piéroni L, et al. Cystatin C: current position and future prospects. Clin Chem Lab Med 2008;46:16641686.
  • 17
    Kyhse-Andersen J, Schmidt C, Nordin G, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994;40:19211926.
  • 18
    Herget-Rosenthal S, Marggraf G, Hüsing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004;66:11151122.
  • 19
    Lassus J. Cystatin C. A measure of renal function, as prognostic risk marker in acute heart failure. Studies on the Cardiorenal Syndrome. Helsinki, Finland: University of Helsinki; 2011. Thesis.
  • 20
    Blaschuk O, Burdzy K, Fritz IB. Purification and characterization of cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. J Biol Chem 1983;258:77147720.
  • 21
    Rosenberg ME, Silkensen J. Clusterin and the kidney. Exp Nephrol 1995;3:914.
  • 22
    Aulitzky WK, Schlegel PN, Wu DF, et al. Measurement of urinary clusterin as an index of nephrotoxicity. Proc Soc Exp Biol Med 1992;199:936.
  • 23
    German AJ, Holden SL, Bissot T, et al. Dietary energy restriction and successful weight loss in obese client-owned dogs. J Vet Int Med 2007;21:11741180.
  • 24
    German AJ, Holden SL, Bissot T, et al. A high protein high fibre diet improves weight loss in obese dogs. Vet J 2010;183:294297.
  • 25
    Raffan E, Holden SL, Cullingham F, et al. Standardized positioning is essential for precise determination of body composition using dual-energy x-ray absorptiometry in dogs. J Nutr 2006; 136(Suppl.):19761978.
  • 26
    National Research Council (NRC). Energy. In: Nutrient Requirements of Dogs and Cats. Washington, DC: The National Academies Press; 2006:2848.
  • 27
    Gentilini F, Dondi F, Mastrorilli C, et al. Validation of a human immunoturbidimetric assay to measure canine albumin in urine and cerebrospinal fluid. J Vet Diagn Invest 2005;17:179183.
  • 28
    Nathan DM, Rosenbaum C, Protasowicki VD. Single-void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care 1987;10:414418.
  • 29
    German AJ, Hervera M, Hunter L, et al. Improvement in insulin resistance and reduction in plasma inflammatory adipokines after weight loss in obese dogs. Domest Anim Endocrinol 2009;37:214226.
  • 30
    Altman DG. Multiple regression. In: Practical Statistics for Medical Research. Chapman and Hall, London, UK; 1996:336351.
  • 31
    International Renal Interest Society. IRIS staging of CKD. Available at Accessed January 24, 2012.
  • 32
    Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation. Am J Kidney Dis 1999;33:10041010.
  • 33
    Henegar JR, Bigler SA, Henegar LK, et al. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001;12:12111217.
  • 34
    Yamka RM, Friesen KG, Frantz NZ. Identification of canine markers related to obesity and the effects of weight loss on the markers of interest. Int J Appl Res Vet Med 2006;4:282292.
  • 35
    Diez M, Michaux C, Jeusette I, et al. Evolution of blood parameters during weight loss in experimental obese Beagle dogs. J Anim Physiol Anim Nutr 2004;88:166171.
  • 36
    Layman DK, Boileau RA, Erickson DJ, et al. A reduced ratio of dietary carbohydrate to protein improves body composition and blood lipid profiles during weight loss in adult women. J Nutr 2003;133:411417.
  • 37
    Noakes M, Keogh JB, Foster PR, Clifton PM. Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. Am J Clin Nutr 2005;81:12981306.
  • 38
    Bodey AR, Mitchell AR. Epidemiological study of blood pressure in domestic dogs. J Small Anim Pract 1996;37:116125.
  • 39
    Montoya JA, Morris PJ, Bautista I, et al. Hypertension: A risk factor associated with weight status in dogs. J Nutr 2006;136:2011S2013S.
  • 40
    Tvarijonaviciute A, Ceron JJ, Holden SL, et al. Obesity-related metabolic dysfunction in dogs: A comparison with human metabolic syndrome. BMC Vet Res 1012;8:147.
  • 41
    Marchesini G, Manini R, Bianchi G, et al. Homocysteine and psychological traits: A study in obesity. Nutrition 2002;18:403407.
  • 42
    Ortega RM, Lopez-Sobaler AM, Andres P, et al. Changes in folate status in overweight/obese women following two different weight control programmes based on an increased consumption of vegetables or fortified breakfast cereals. Br J Nutr 2006;96:712718.
  • 43
    Braun JP, Perxachs A, Pe′Chereau D, De La Farge F. Plasma cystatin C in the dog: Reference values and variations with renal failure. Comp Clin Pathol 2002;11:4449.
  • 44
    Miyagawa Y, Takemura N, Hirose H. Evaluation of the measurement of serum cystatin C by an enzyme-linked immunosorbent assay for humans as a marker of the glomerular filtration rate in dogs. J Vet Med Sci 2009;71:11691176.
  • 45
    Muntner P, Winston J, Uribarri J, et al. Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med 2008;121:341348.
  • 46
    Naour N, Fellahi S, Renucci JF, et al. Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity 2009;17:21212126.
  • 47
    Jenne DE, Lowin B, Peitsch MC, et al. Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma. J Biol Chem 1991;266:1103011036.
  • 48
    Chapman MJ. Comparative analysis of mammalian plasma lipoproteins. Methods Enzymol 1986;128:70143.
  • 49
    Jeusette IC, Lhoest ET, Istasse LP, Díez MO. Influence of obesity on plasma lipid and lipoprotein concentrations in dogs. Am J Vet Res 2005;66:8186.
  • 50
    Oberbach A, Blüher M, Wirth H, et al. Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Prot Res 2011;10:47694788.
  • 51
    Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:8995.
  • 52
    Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50:889896.
  • 53
    Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci 2002;57:359365.
  • 54
    Jones SE, Jomary C. Cluterin. Int J Bioch Cell Biol 2002;34:427431.
  • 55
    Pattison JS, Folk LC, Madsen RW, Booth FW. Selected contribution: Identification of differentially expressed genes between young and old rat soleus muscle during recovery from immobilization-induced atrophy. J Appl Physiol 2003;95:21712179.
  • 56
    García-Martínez JD, Tvarijonaviciute A, Cerón JJ, et al. Urinary clusterin as a renal marker in dogs. Vet Diagn Invest. 2012;24:3016.
  • 57
    Monti P, Benchekroun G, Berlato D, Archer J. Initial evaluation of canine urinary cystatin C as a marker of renal tubular function. J Small Anim Pract 2012;53:2549.
  • 58
    Association of American Feed Control Officials (AAFCO). Dogs and cats nutrient profiles. Oxford, IN: AAFCO Official Publication; 2003:125140.